发明授权
- 专利标题： Anti-TNF-anti-IL-17 bispecific antibodies
- 专利标题（中）： 抗TNF-抗IL-17双特异性抗体
-
申请号： US14195885申请日： 2014-03-04
-
公开(公告)号： US09416182B2公开(公告)日： 2016-08-16
- 发明人: Barrett Allan , Andrew Lawrence Glasebrook , Jirong Lu , Ying Tang , Derrick Ryan Witcher , Donmienne Doen Mun Leung , Pia Pauliina Yachi , Andrew Charles Vendel
- 申请人： Eli Lilly and Company
- 申请人地址： US IN Indianapolis
- 专利权人： Eli Lilly and Company
- 当前专利权人： Eli Lilly and Company
- 当前专利权人地址： US IN Indianapolis
- 代理商 Gregory A. Cox
- 主分类号： C07K16/00
- IPC分类号： C07K16/00 ; A61K39/395 ; A61K39/40 ; C07K16/24 ; C07K1/00 ; A61K39/00
摘要：
Bispecific antibodies are provided that specifically bind both Tumor Necrosis Factor alpha (TNFα) and Interleukin-17 (IL-17). The bispecific antibodies of the invention are useful for treating various autoimmune diseases, including Rheumatoid Arthritis (RA), Psoriatic Arthritis (PsA), and Ankylosing Spondylitis (AS).
公开/授权文献
- US20140255406A1 ANTI-TNF-ANTI-IL-17 BISPECIFIC ANTIBODIES 公开/授权日：2014-09-11
信息查询
